Property:Outcome specification
This is a property of type Text.
S
Shapiro et al. (2016): Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) +
Interactions between D<sub>3</sub> and anastrozole and letrozole +
Shapiro et al. (2016): Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) +
Reproductive hormone concentrations for estrone, estradiol, testosterone (free and total) and sex-hormone binding globulin +
Sharp et al. (2010): A randomised, controlled trial of the psychological effects of reflexology in early breast cancer +
Psychiatric morbidity rate +
Sharp et al. (2010): A randomised, controlled trial of the psychological effects of reflexology in early breast cancer +
QQL with FACT-B physical, functional, emotional, social and additional worry scale (baseline, 18 weeks post surgery, 24 weeks post surgery) +
Sharp et al. (2010): A randomised, controlled trial of the psychological effects of reflexology in early breast cancer +
Anxiety and Depression (Baseline, 18 weeks post surgery, 24 weeks post surgery) +
Sharp et al. (2010): A randomised, controlled trial of the psychological effects of reflexology in early breast cancer +
QQL and FACT-B: TOI-Scale at 18 weeks post surgery +
Sharp et al. (2010): A randomised, controlled trial of the psychological effects of reflexology in early breast cancer +
Relaxation Scale (Baseline, 18 weeks pot surgery; 24 weeks post surgery) +
Sharp et al. (2010): A randomised, controlled trial of the psychological effects of reflexology in early breast cancer +
Trial Outcome Index (TOI) from the FACT-B at Baseline end-point 1 (week 18 post surgery). +
Sharp et al. (2010): A randomised, controlled trial of the psychological effects of reflexology in early breast cancer +
Mood with other scales (Baseline, 18 weeks post surgery; 24 weeks post surgery) +
Shokri et al. (2017): Comparison of the Complications of Platinum-Based Adjuvant Chemotherapy With and Without Ginger in a Pilot Study on Ovarian Cancer Patients +
Disease-free 12-month survival: +
Shokri et al. (2017): Comparison of the Complications of Platinum-Based Adjuvant Chemotherapy With and Without Ginger in a Pilot Study on Ovarian Cancer Patients +
Results of CT scans in terms of the presence of metastasis at different times +
Shokri et al. (2017): Comparison of the Complications of Platinum-Based Adjuvant Chemotherapy With and Without Ginger in a Pilot Study on Ovarian Cancer Patients +
Adverse effects +
Shooriabi et al. (2016): The effect of ginger extract on radiotherapy-oriented salivation in patients with xerostomia: A double-blind controlled study +
Amount/weight of saliva, unstimulated +
Shooriabi et al. (2016): The effect of ginger extract on radiotherapy-oriented salivation in patients with xerostomia: A double-blind controlled study +
Dry mouth, difficulty chewing / swallowing / speaking, burning sensation in the mouth, bad taste, waking up at night, prosthetic mesh, meeting people, talking to people, leaving the house +
Sontakke et al. (2003): Ginger as an antiemetic in nausea and vomiting induced by chemotherapy: A randomized, cross-over, double blind study +
No nausea=complete control, mild to moderate=partial control, severe nausea=no control +
Sontakke et al. (2003): Ginger as an antiemetic in nausea and vomiting induced by chemotherapy: A randomized, cross-over, double blind study +
NA +
Sontakke et al. (2003): Ginger as an antiemetic in nausea and vomiting induced by chemotherapy: A randomized, cross-over, double blind study +
Complete control of vomiting with low Cth dose (500-600 mg) + low emetogenic Cth (N=20) vs. low Cth dose + high emetogenic Cth (N=7) vs. high Cth dose (900-1000 mg) with further Cth (N=23) +
Sontakke et al. (2003): Ginger as an antiemetic in nausea and vomiting induced by chemotherapy: A randomized, cross-over, double blind study +
Vomiting frequency (divided into: no vomiting=complete control, 1-2x=partial control, ≥3=no control) +
Stauder et al. (1991): Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzyme +
Average tolerability scored by patient and doctor on a scale from 1=very good to 5=bad;
Therpy result scored by patient and doctor on a scale from 1 to 4=unsatisfactory +
Stauder et al. (1991): Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzyme +
Influence on the side effects of radiotherapy +